Login / Signup

Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real-World Data.

Maximilian Leo MüllerEkaterina LatinovaKarl StanglIsabel MattigSebastian SpethmannDaniel R MessroghliKatrin HahnUlf LandmesserBettina Heidecker
Published in: Journal of the American Heart Association (2024)
Treatment of ATTR-CA with tafamidis led to substantial improvements of clinical outcome. NYHA classification at treatment initiation is a reliable tool to provide patients with individualized prognostic information.
Keyphrases